You are here
Prevention of symptomatic skeletal events in patients with genitourinary (gu) tumours and bone metastases treated with denosumab or zoledronic acid.
Speaker: K. Fizazi, Villejuif (FR) Duration: 11:45 - 11:52
Please watch these webcasts in a browser higher than Internet Explorer 8, or use Google Chrome, Firefox, Opera or Safari.
If you are unsure of your current browser you can check on: www.whatbrowser.org.